NCT00720941 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 557
- group Id
- BG001
- value
- 553
- group Id
- BG002
- value
- 1110
- units
- Participants
- groups
- description
- Participants were administered pazopanib 800 mg (2 x 400 mg tablets) orally OD continuously. Pazopanib was to be taken at least one hour before or at least two hours after a meal. Participants received study treatment until disease progression, death, unacceptable toxicity, or withdrawal of consent for any other reasons.
- id
- BG000
- title
- Pazopanib 800 mg
- description
- Participants were administered sunitinib 50 mg orally once daily in 6-week cycles (4 weeks of treatment, followed by 2 weeks without treatment). Participants received study treatment until disease progression, death, unacceptable toxicity, or withdrawal of consent for any other reasons.
- id
- BG001
- title
- Sunitinib 50 mg
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.89
- value
- 60.9
- group Id
- BG001
- spread
- 10.98
- value
- 61.2
- group Id
- BG002
- spread
- 10.93
- value
- 61.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 159
- group Id
- BG001
- value
- 138
- group Id
- BG002
- value
- 297
- title
- Female
- measurements
- group Id
- BG000
- value
- 398
- group Id
- BG001
- value
- 415
- group Id
- BG002
- value
- 813
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 349
- group Id
- BG001
- value
- 358
- group Id
- BG002
- value
- 707
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 194
- group Id
- BG001
- value
- 188
- group Id
- BG002
- value
- 382
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 15
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native & White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Unknown
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 557
- group Id
- BG001
- value
- 553
- group Id
- BG002
- value
- 1110
- units
- Participants
- groups
- description
- Participants were administered pazopanib 800 mg (2 x 400 mg tablets) orally OD continuously. Pazopanib was to be taken at least one hour before or at least two hours after a meal. Participants received study treatment until disease progression, death, unacceptable toxicity, or withdrawal of consent for any other reasons.
- id
- BG000
- title
- Pazopanib 800 mg
- description
- Participants were administered sunitinib 50 mg orally once daily in 6-week cycles (4 weeks of treatment, followed by 2 weeks without treatment). Participants received study treatment until disease progression, death, unacceptable toxicity, or withdrawal of consent for any other reasons.
- id
- BG001
- title
- Sunitinib 50 mg
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.89
- value
- 60.9
- group Id
- BG001
- spread
- 10.98
- value
- 61.2
- group Id
- BG002
- spread
- 10.93
- value
- 61.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 159
- group Id
- BG001
- value
- 138
- group Id
- BG002
- value
- 297
- title
- Female
- measurements
- group Id
- BG000
- value
- 398
- group Id
- BG001
- value
- 415
- group Id
- BG002
- value
- 813
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 349
- group Id
- BG001
- value
- 358
- group Id
- BG002
- value
- 707
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 194
- group Id
- BG001
- value
- 188
- group Id
- BG002
- value
- 382
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 15
- title
- African American/African Heritage
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native & White
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Unknown
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle